Table 3.
Back transformed (from log scale) estimates in percent difference between Mondays vs the other weekdays for glucose, insulin, glucagon, GIP and GLP-1.
Unadjusted | Adjusted for age, sex, BMI, smoking status and fasting duration | |||||||
---|---|---|---|---|---|---|---|---|
n | Estimate (%) 95% CI | P | n | Estimate (%) 95% CI | P | |||
Plasma glucose | ||||||||
Fasting | 1718 | 0.9 | (−0.9,2.7) | 0.316 | 1706 | 1.7 | (0.0,3.4) | 0.051 |
30 min | 1703 | −2.1 | (−4.8,0.7) | 0.134 | 1691 | −0.9 | (−3.5,1.8) | 0.508 |
120 min | 1711 | −5.1 | (−9.5,−0.6) | 0.028 | 1699 | −2.9 | (−7.2,1.5) | 0.187 |
rAUC0–30 | 1703 | −1.8 | (−3.1,−0.5) | 0.007 | 1691 | −1.5 | (−2.8,−0.2) | 0.020 |
rAUC0–120 | 1699 | −3.6 | (−5.6,−1.6) | <0.001 | 1687 | −2.9 | (−4.8,−0.9) | 0.004 |
Plasma insulin | ||||||||
Fasting | 1717 | 14.8 | (4.4,26.3) | 0.005 | 1705 | 20.6 | (11.2,30.7) | <0.001 |
30 min | 1700 | 8.7 | (−1.7,20.1) | 0.104 | 1688 | 13.1 | (2.8,24.4) | 0.012 |
120 min | 1709 | 1.8 | (−9.9,15.1) | 0.774 | 1697 | 9.1 | (−2.5,22.1) | 0.128 |
rAUC0–30 | 1699 | −5.5 | (−12.4,2.0) | 0.145 | 1687 | −6.4 | (−13.1,0.9) | 0.084 |
rAUC0–120 | 1695 | −8.4 | (−14.9,−1.5) | 0.019 | 1683 | −8.4 | (−14.7,−1.5) | 0.017 |
Plasma glucagon | ||||||||
Fasting | 1467 | 3.8 | (−5.7,14.2) | 0.445 | 1455 | 6.1 | (−3.2,16.2) | 0.207 |
30 min | 1454 | −0.8 | (−10.1,9.3) | 0.864 | 1442 | 3.1 | (−6.0,13.1) | 0.514 |
120 min | 1458 | 2.7 | (−9.9,17.0) | 0.693 | 1446 | 5.7 | (−7.2,20.5) | 0.405 |
rAUC0–30 | 1451 | −2.7 | (−6.2,1.1) | 0.158 | 1439 | −2.0 | (−5.6,1.8) | 0.299 |
rAUC0–120 | 1443 | −1.8 | (−7.2,3.9) | 0.537 | 1431 | −0.9 | (−6.3,4.9) | 0.765 |
Plasma GIP | ||||||||
Fasting | 1403 | −1.3 | (−9.5,7.8) | 0.777 | 1391 | −2.1 | (−10.3,6.8) | 0.626 |
30 min | 1391 | 3.4 | (−3.7,11.0) | 0.354 | 1380 | 4.0 | (−3.0,11.6) | 0.270 |
120 min | 1395 | 3.8 | (−3.1,11.2) | 0.292 | 1383 | 3.6 | (−3.0,10.7) | 0.296 |
rAUC0–30 | 1387 | 4.7 | (−2.7,12.7) | 0.221 | 1376 | 5.8 | (−1.6,13.9) | 0.129 |
rAUC–120 | 1378 | 5.1 | (−3.1,14.1) | 0.228 | 1367 | 6.3 | (−2.0,15.2) | 0.139 |
Plasma GLP-1 | ||||||||
Fasting | 1465 | −7.4 | (−17.4,3.9) | 0.193 | 1453 | −3.7 | (−14.1,7.9) | 0.518 |
30 min | 1454 | −2.3 | (−11.6,7.9) | 0.646 | 1442 | 1.1 | (−8.2,11.4) | 0.826 |
120 min | 1458 | 0.5 | (−7.6,9.3) | 0.911 | 1446 | 2.2 | (−5.6,10.6) | 0.595 |
rAUC0–30 | 1449 | 3.4 | (−5.5,13.2) | 0.464 | 1437 | 2.8 | (−6.0,12.4) | 0.549 |
rAUC0–120 | 1441 | 6.2 | (−4.0,17.6) | 0.243 | 1429 | 4.7 | (−5.1,15.6) | 0.359 |
Linear regression models.
GIP glucose-dependent insulinotropic polypeptide; GLP-1, and glucagon-like peptide 1; rAUC0–30, relative early response; rAUC0–120, relative total response.